Press release
Global Impact of Covid-19 on Pharmacogenomics (PGx) Market to Record Significant Revenue Growth During the Forecast Period 2020–2027 | Abbott Laboratories, Admera Health, LLC, Agena Biosciences, Inc., Cancer Genetics, Inc., etc
Pharmacogenomics (PGx) Market
The Global Pharmacogenomics (PGx) Market report gives a comprehensive overview of the Pharmacogenomics (PGx) market scenario to present accurate forecasts of the upcoming years with special focus on the competitive landscape, market segmentation, current, and emerging trends, and strategic recommendations to help readers gain a robust footing in the market. The report also focuses on the comprehensive analysis of the competitive landscape along with descriptive company profiles, market share, product portfolio, financial standings, market reach, global position, and strategic business expansion plans. The global Pharmacogenomics (PGx) market is forecasted to grow at a rate of 8.7% from USD 5.66 billion in 2018 to USD 11.01 billion in 2027.
The report is furnished with the latest market scenario pertaining to the COVID-19 pandemic and its after-effects on the Pharmacogenomics (PGx) industry and the key segments. The pandemic has disrupted the workflow of the industry and created financial difficulties. The report assesses the complete impact of the pandemic on the market and offers key insights into the market scenario along with trends and demands disruptions. The report also offers an outlook on the market scenario in the forecast timeline.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2296
Some of the players profiled in the report are Abbott Laboratories, Admera Health, LLC, Agena Biosciences, Inc., Cancer Genetics, Inc., Dynamic DNA Laboratories, F. Hoffmann-La Roche Ltd, geneOmbio Technologies Pvt Ltd., Genomic Health, Inc., Illumina, Inc., and Laboratory Corporation of America Holdings and others.
The Global Pharmacogenomics (PGx) Market is segmented as follows:
Products and Services Outlook (Revenue, USD Billion; 2017-2027)
Products
Kits
Assay & Reagents
Instruments
Software
Services
Genotyping
SNP Identification
Pharmacogenetics Testing
Other Services
Technology Outlook (Revenue, USD Billion; 2017-2027)
Polymerase Chain Reaction (PCR)
Real Time PCR
qPCR
Digital PCR
DNA Sequencing/Next Generation Sequencing (NGS)
Nucleic Acid Amplification Tests (NAATs)
Mass Spectrometry
Gel Electrophoresis
Hybridization
Fluorescence In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization (CISH)
Others
Microarray
Others
Application Outlook (Revenue, USD Billion; 2017-2027)
Oncology
Infectious Diseases
Neurology/Psychiatry
Cardiovascular
Others
End Use Outlook (Revenue, USD Billion; 2017-2027)
Research Organisation
Pharmaceutical Companies
Diagnostic Centers
Others
Market Segmentation by Regions:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2296
Key Point Summary of the Report:
The global Pharmacogenomics (PGx) market research report is an investigative study offering key insights into the latest growth trends, developments, technological and product advancements, and the research and development scenario. The report also covers the market aspects that directly influence the growth of the market. These features include strategies undertaken by the prominent players, their expansion tactics, and the product portfolios of the companies, and micro and macro-economic factors.
The study also analyses the crucial market aspects, including R&D, product launches and brand promotions, mergers and acquisitions, collaborations, joint ventures, and the growth pattern on both regional and global levels. The report offers an in-depth evaluation of factors such as cost, capacity, rates of production and consumption, gross revenue, profit margin, demand and supply ratio, import/export, market share, market size, and market trends.
To know more about the report, visit @ https://www.reportsanddata.com/report-detail/pharmacogenomics-pgx-market
To summarize everything stated above, the report offers key insights into the Pharmacogenomics (PGx) market to allow the reader to gain a complete understanding of the Global Pharmacogenomics (PGx) Market through accurate estimations, a panoramic view of the market scenario, competitive landscape, factors influencing the growth of the market, driving factors, restraints, regulatory framework, growth prospects, and opportunities, and factors propelling the market forward. The research study offers an in-depth view of the industry to offer a competitive edge to the reader and help them in formulating beneficial investment plans. The report provides a comprehensive overview of the market with facts relating to the past, present, and future of the Global Pharmacogenomics (PGx) Market.
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2296
Thank you for reading the report. The report can be customized as per the requirements of the clients. For further information or queries about customization options, please reach out to us, and we will offer you the report best suited for your needs.
40 Wall St. 28th floor New York City, NY 10005 United States
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Impact of Covid-19 on Pharmacogenomics (PGx) Market to Record Significant Revenue Growth During the Forecast Period 2020–2027 | Abbott Laboratories, Admera Health, LLC, Agena Biosciences, Inc., Cancer Genetics, Inc., etc here
News-ID: 2148430 • Views: …
More Releases from Report And Data
Automotive On-Board AC/DC Power Inverters Market to Reach USD 3.9 Billion by 203 …
The global Automotive On-Board AC/DC Power Inverters Market is projected to grow from USD 1.2 billion in 2024 to USD 3.9 billion by 2034, expanding at a strong CAGR of 12.70%, according to the latest industry analysis. This rapid growth is being fueled by the rising adoption of electric vehicles (EVs), advancements in in-car electronics, and the growing need for power solutions in modern vehicles.
To avail Sample Copy of the…
Global Automotive Cabin Insulation Market to Reach USD 4.7 Billion by 2034, Driv …
The global Automotive Cabin Insulation Market is on a strong growth trajectory, projected to rise from USD 2.0 billion in 2024 to USD 4.7 billion by 2034, growing at a CAGR of 8.7%, according to a new industry report. The growth is fueled by rising consumer expectations for quieter, more comfortable vehicles and increasing focus on energy efficiency and environmental standards.
To avail Sample Copy of the report @ https://www.reportsanddata.com/sample-enquiry-form/19439
Comfort and…
Automotive 48V Systems Market Size: 2034 Statistics
The global Automotive 48V Systems Market is poised for strong growth, expected to rise from USD 1.8 billion in 2024 to USD 5.3 billion by 2034. This represents a healthy annual growth rate of nearly 11%, fueled by rising demand for fuel-efficient vehicles, tighter emissions regulations, and the push toward vehicle electrification.
Mild hybrid vehicles lead the market today, offering a practical way for automakers to cut emissions while improving fuel…
3D Printing Automotive Market to Soar from $3.36 Billion in 2024 to $25.61 Billi …
The global 3D printing automotive market is set for remarkable growth, projected to rise from USD 3.36 billion in 2024 to USD 25.61 billion by 2034, with an impressive annual growth rate of 22.53%. This growth is driven by the rising use of 3D printing for faster prototyping, efficient production, and reduced material waste across the automotive industry.
Prototyping is currently the largest application of 3D printing in automobiles, helping manufacturers…
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
